Commonwealth Equity Services, LLC Sera Prognostics, Inc. Transaction History

Commonwealth Equity Services, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$5.05 - $10.0 $62,948 - $124,650	-12,465 Reduced 17.66%	58,123 $529,000
Q4 2022 Feb 07, 2023	SELL	$1.16 - $1.8 $1,118 - $1,735	-964 Reduced 1.35%	70,588 $88,000
Q3 2022 Nov 14, 2022	SELL	$1.55 - $2.71 $65 - $113	-42 Reduced 0.06%	71,552 $114,000
Q2 2022 Jul 19, 2022	BUY	$1.2 - $3.62 $85,912 - $259,170	71,594 New	71,594 $117,000

20.3M

120K

Ticker SERA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 29,596,900
Market Cap $201M
Description
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.